A Randomized Controlled Clinical Study for Validating the Effectiveness of a Mobile Health Management Program Aimed At Colorectal Cancer Survivors with Comorbid Chronic Conditions
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus
- Sponsor
- Seoul National University Hospital
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Fasting Blood Sugar
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this clinical trial is to evaluate if a mobile health management program can improve chronic disease management among colorectal cancer survivors with comorbid conditions such as hypertension, diabetes, and dyslipidemia. The main questions it aims to answer are:
Does the mobile health application improve clinical outcomes such as blood pressure, blood glucose levels, and lipid profiles? Does the application enhance participants' health behaviors and self-management capabilities? Researchers will compare the mobile health application group to the educational booklet group to see if the digital intervention leads to better health outcomes and adherence to lifestyle changes
Investigators
Eligibility Criteria
Inclusion Criteria
- •Individuals aged 19 years or older Colorectal cancer survivors (patients within 5 years of completion of curative treatments such as surgery, radiation therapy, or chemotherapy) who also have chronic conditions (hypertension, dyslipidemia, or diabetes)
- •Specific registration criteria:
- •Diabetes: Fasting blood sugar (FBS) ≥ 126 mg/dL or HbA1c ≥ 6.5% Dyslipidemia: Low-density lipoprotein cholesterol (LDL) ≥ 130 mg/dL Hypertension: Systolic blood pressure (SBP) ≥ 140 mmHg or Diastolic blood pressure (DBP) ≥ 90 mmHg Individuals who understand the purpose of this study and provide informed consent to participate Individuals who own and use a smartphone (able to use an ICT-based health management program)
Exclusion Criteria
- •Individuals who are unable to speak, listen, or read in Korean Individuals determined by a physician to be physically or mentally unfit (e.g., shortness of breath, severe depression) to participate in the study Individuals who are deemed unable to use the ICT-based program
Outcomes
Primary Outcomes
Fasting Blood Sugar
Time Frame: From enrollment to the end of treatment at 3months
Check for decreased blood sugar levels
Hemoglobin A1c
Time Frame: From enrollment to the end of treatment at 3months
check if the level has decreased
Total Cholesterol
Time Frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
LDL Cholesterol
Time Frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Systolic and Diastolic Blood Pressure
Time Frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Body Weight
Time Frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Body Mass Index
Time Frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Physical Activity Levels
Time Frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Secondary Outcomes
- Improvement in Health Management Capability(From enrollment to the end of treatment at 3months)
- Increase in Health Behavior Patterns(From enrollment to the end of treatment at 3months)
- Emotional and Subjective Health Status(From enrollment to the end of treatment at 3months)